Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Fenaux

Showing results (41-50 of 412) with videos related to

Pageof 42
Sort By:
La Revue De Medecine Interne|January 1, 1995
[Systemic diseases in myelodysplastic syndromes]M Hebbar, K Hebbar-Savéan, P Fenaux
Seminars in Hematology|April 1, 1996
Cytogenetics of myelodysplastic syndromesP Fenaux, P Morel, J L Lai
Current Topics in Microbiology and Immunology|January 16, 2007
Treatment of acute promyelocytic leukemia by retinoidsP Fenaux, Z Z Wang, L Degos
Leukemia|October 25, 2007
Defects of immune surveillance offer new insights into the pathophysiology and therapy of myelodysplastic syndromesJ-J Kiladjian, P Fenaux, A Caignard
Cancer Genetics and Cytogenetics|November 1, 1994
Reassessment of an apparent t(12;17)(p11;p11) as an unbalanced t(17;21)(p11;q11) in a case of B-cell chronic lymphocytic leukemia by fluorescence in situ hybridizationM Flactif, J L Laï, P Fenaux
Leukemia|October 1, 1994
Absence of BCR-ABL rearrangement (with m-bcr breakpoint) in chronic myelomonocytic leukemiaN Henic, C Preudhomme, M Vanrumbeke, et al.
La Revue De Medecine Interne|September 21, 2010
[Systemic and autoimmune manifestations in myelodysplastic syndromes]O Fain, T Braun, J Stirnemann, et al.
Lancet (London, England)|April 23, 1994
Tretinoin with chemotherapy in newly diagnosed acute promyelocytic leukaemia. European APL GroupP Fenaux, C Chastang, C Chomienne, et al.
Pathologie-Biologie|August 12, 2006
The first international meeting on V617F JAK2 mutation and its relevance in Philadelphia-negative myeloproliferative disordersJ J Kiladjian, N Casadevall, W Vainchenker, et al.
Leukemia|June 1, 1994
Fluorescence in situ hybridization improves the detection of monosomy 7 in myelodysplastic syndromesM Flactif, J L Lai, C Preudhomme, et al.
Pageof 42

Showing results (41-50 of 412) with videos related to

Sort By:
Pageof 42
La Revue De Medecine Interne|January 1, 1995
[Systemic diseases in myelodysplastic syndromes]M Hebbar, K Hebbar-Savéan, P Fenaux
Seminars in Hematology|April 1, 1996
Cytogenetics of myelodysplastic syndromesP Fenaux, P Morel, J L Lai
Current Topics in Microbiology and Immunology|January 16, 2007
Treatment of acute promyelocytic leukemia by retinoidsP Fenaux, Z Z Wang, L Degos
Leukemia|October 25, 2007
Defects of immune surveillance offer new insights into the pathophysiology and therapy of myelodysplastic syndromesJ-J Kiladjian, P Fenaux, A Caignard
Cancer Genetics and Cytogenetics|November 1, 1994
Reassessment of an apparent t(12;17)(p11;p11) as an unbalanced t(17;21)(p11;q11) in a case of B-cell chronic lymphocytic leukemia by fluorescence in situ hybridizationM Flactif, J L Laï, P Fenaux
Leukemia|October 1, 1994
Absence of BCR-ABL rearrangement (with m-bcr breakpoint) in chronic myelomonocytic leukemiaN Henic, C Preudhomme, M Vanrumbeke, et al.
La Revue De Medecine Interne|September 21, 2010
[Systemic and autoimmune manifestations in myelodysplastic syndromes]O Fain, T Braun, J Stirnemann, et al.
Lancet (London, England)|April 23, 1994
Tretinoin with chemotherapy in newly diagnosed acute promyelocytic leukaemia. European APL GroupP Fenaux, C Chastang, C Chomienne, et al.
Pathologie-Biologie|August 12, 2006
The first international meeting on V617F JAK2 mutation and its relevance in Philadelphia-negative myeloproliferative disordersJ J Kiladjian, N Casadevall, W Vainchenker, et al.
Leukemia|June 1, 1994
Fluorescence in situ hybridization improves the detection of monosomy 7 in myelodysplastic syndromesM Flactif, J L Lai, C Preudhomme, et al.
Pageof 42